Literature DB >> 16439402

Medical treatment of early breast cancer. IV: neoadjuvant treatment.

Ian Smith1, Susan Chua.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16439402      PMCID： PMC1352059          DOI： 10.1136/bmj.332.7535.223

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

Review 1.  Neoadjuvant chemotherapy for bladder cancer.

Authors:  Peter C Black; Gordon A Brown; H Barton Grossman; Colin P Dinney
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

2.  Potentiation of the growth inhibition activity of 2-({4-[4-(acridin-9-ylamino)phenylthio]phenyl}(2-hydroxyethyl)amino)ethan-1-ol (CK0402) by Herceptin in SKBR-3 human breast cancer cells.

Authors:  Yuan-Wan Sun; Ting-Kuang Niu; Jin-Ming Yang; Chul-Hoon Kwon; Kuen-Yuan Chen; Kun-Ming Chen
Journal:  Exp Ther Med       Date:  2010-05-01       Impact factor: 2.447

3.  Neoadjuvant chemotherapy and short-term morbidity in patients undergoing mastectomy with and without breast reconstruction.

Authors:  Nicholas B Abt; José M Flores; Pablo A Baltodano; Karim A Sarhane; Francis M Abreu; Carisa M Cooney; Michele A Manahan; Vered Stearns; Martin A Makary; Gedge D Rosson
Journal:  JAMA Surg       Date:  2014-10       Impact factor: 14.766

4.  Contrast-enhanced US and MRI for assessing the response of breast cancer to neoadjuvant chemotherapy().

Authors:  B Corcioni; L Santilli; S Quercia; C Zamagni; D Santini; M Taffurelli; S Mignani
Journal:  J Ultrasound       Date:  2008-11-14

5.  Indication of metronomic chemotherapy for metastatic breast cancer: Clinical outcomes and responsive subtypes.

Authors:  Keiichi Kontani; Shin-Ichiro Hashimoto; Chisa Murazawa; Shoko Norimura; Hiroaki Tanaka; Masahiro Ohtani; Naomi Fujiwara-Honjo; Manabu Date; Koji Teramoto; Hitoshi Houchi; Hiroyasu Yokomise
Journal:  Mol Clin Oncol       Date:  2016-03-30

6.  Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistance.

Authors:  Derek W Edwardson; Justin Boudreau; Jonathan Mapletoft; Carita Lanner; A Thomas Kovala; Amadeo M Parissenti
Journal:  PLoS One       Date:  2017-09-15       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.